• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [27 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2025 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Delgocitinib (moderate to severe chronic hand eczema) – benefit assessment according to §35a Social Code Book V]
2025 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Delgocitinib (moderate to severe chronic hand eczema) – addendum to Project A24-107]
2024 NIHR Health Technology Assessment programme Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT
2024 NIHR Health Technology Assessment programme Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
2024 Agency for Care Effectiveness (ACE) Abrocitinib, baricitinib, upadacitinib and dupilumab for treating atopic dermatitis
2024 NIHR Health Technology Assessment programme Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
2024 NIHR Health Technology Assessment programme Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT
2024 Institute for Clinical Effectiveness and Health Policy (IECS) [Partially hydrolyzed formula to prevent cow’s milk allergy]
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tralokinumab (moderate-to-severe atopic dermatitis in adolescents) - Benefit assessment according to § 35a Social Code Book V]
2023 NIHR Health Technology Assessment programme Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT
2022 NIHR Health Technology Assessment programme Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
2022 National Institute for Health and Care Excellence (NICE) Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis. NICE technology appraisal guidance 814
2022 Malaysian Health Technology Assessment (MaHTAS) Sublingual immunotherapy (SLIT) for atopy (allergic rhinitis, eczema and asthma)
2021 Institute for Clinical and Economic Review (ICER) JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value
2019 NIHR Health Technology Assessment programme A behaviour change package to prevent hand dermatitis in nurses working in health care: the SCIN cluster RCT
2018 NIHR Health Technology Assessment programme Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT
2017 NIHR Health Technology Assessment programme Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial
2016 NIHR Horizon Scanning Centre (NIHR HSC) Dupilumab - atopic dermatitis: moderate to severe; inadequate response to treatment with topical medications or for whom topical treatments are otherwise medically inadvisable – second line
2011 The Netherlands Organisation for Health Research and Development (ZonMw) [Transmural care for hand eczema; a randomised controlled trial and cost-effectiveness evaluation]
2010 NIHR Health Technology Assessment programme Alitretinoin for the treatment of severe chronic hand eczema
2009 National Institute for Health and Care Excellence (NICE) Alitretinoin for the treatment of severe chronic hand eczema. NICE technology appraisal guidance 177
2007 National Institute for Health and Care Excellence (NICE) Grenz rays therapy for inflammatory skin conditions. NICE interventional procedures guidance 236
2007 NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2004 Quality Improvement Scotland (NHS QIS ) Tacrolimus and pimecrolimus for atopic eczema
2001 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tacrolimus ointment for the treatment of atopic dermatitis
2001 NIHR Horizon Scanning Centre (NIHR HSC) New products for atopic dermatitis - horizon scanning review
2000 NIHR Health Technology Assessment programme Systematic review of treatments for atopic eczema